Bill Commons

TN SB 817

died on adjournment

Drugs, Prescription - As enacted, authorizes a healthcare practitioner to prescribe and a pharmacist to dispense a prescribed, bronchodilator rescue inhaler to an authorized entity to be administered to a person believed to be experiencing asthma symptoms or respiratory distress in an emergency situation, under a standing protocol from the healthcare practitioner; encourages schools in LEAs and public charter schools to keep bronchodilator rescue inhalers to be administered to students believed to be having asthma symptoms or in respiratory distress in an emergency situation. - Amends TCA Title 49; Title 53; Title 63 and Title 68.

Tennessee · 114S1 · upper

Quick answers

Did TN SB 817 pass?

No. TN SB 817 died when the 114S1 session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-05-08): Comp. became Pub. Ch. 346

What is TN SB 817 about?

TN SB 817 is a bill in the 114S1 titled “Drugs, Prescription - As enacted, authorizes a healthcare practitioner to prescribe and a pharmacist to dispense a prescribed, bronchodilator rescue inhaler to an authorized entity to be administered to a person believed to be experiencing asthma symptoms or respiratory distress in an emergency situation, under a standing protocol from the healthcare practitioner; encourages schools in LEAs and public charter schools to keep bronchodilator rescue inhalers to be administered to students believed to be having asthma symptoms or in respiratory distress in an emergency situation. - Amends TCA Title 49; Title 53; Title 63 and Title 68.”.

Who sponsors TN SB 817?

Lowe is the primary sponsor of TN SB 817.

Introduced
2025-02-10
Latest action
2025-05-08 — Comp. became Pub. Ch. 346
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Loweprimary

Committees

Not provided by source.

Action timeline

  1. 2025-02-04

    Filed for introduction

    filing

  2. 2025-02-10

    Introduced, Passed on First Consideration

    introduction

  3. 2025-02-12

    Passed on Second Consideration, refer to Senate Education Committee

    referral-committee

  4. 2025-02-26

    Sponsor(s) Added.

    sponsorship

  5. 2025-02-27

    Placed on Senate Education Committee calendar for 3/5/2025

  6. 2025-03-05

    Recommended for passage with amendment/s, refer to Senate Finance, Ways, and Means Committee Ayes 9, Nays 0 PNV 0

  7. 2025-03-11

    Placed on Senate Finance, Ways, and Means Committee calendar for 3/18/2025

  8. 2025-03-18

    Action deferred in Senate Finance, Ways, and Means Committee to 4/1/2025

  9. 2025-03-25

    Placed on Senate Finance, Ways, and Means Committee calendar for 4/1/2025

  10. 2025-04-01

    Sponsor(s) Added.

    sponsorship

  11. 2025-04-01

    Recommended for passage, refer to Senate Calendar Committee

  12. 2025-04-07

    Placed on Senate Regular Calendar for 4/9/2025

  13. 2025-04-09

    Sponsor(s) Added.

    sponsorship

  14. 2025-04-09

    Companion House Bill substituted

    substitution

  15. 2025-05-08

    Comp. became Pub. Ch. 346

Versions

Documents

Votes

  • SENATE EDUCATION COMMITTEE: Recommended for passage with amendment/s, refer to Senate Finance, Ways, and Means Committee Ayes 9, Nays 0 PNV 0 3/5/2025 Passed

    2025-03-05 · pass · 9-0

  • SENATE FINANCE, WAYS AND MEANS COMMITTEE: Recommended for passage, refer to Senate Calendar Committee 4/1/2025 Passed (1)

    2025-04-01 · pass · 10-0

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:32:51.339172Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TN&identifier=SB 817. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.